Griffin Bruce A, Lovegrove Julie A
Department of Nutrition, Food & Exercise Sciences, University of Surrey, GuildfordGU2 7XH, UK.
Hugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular & Metabolic Research, Department of Food and Nutritional Sciences, University of Reading, ReadingRG6 6DZ, UK.
Proc Nutr Soc. 2025 Feb;84(1):87-97. doi: 10.1017/S0029665124000107. Epub 2024 Jan 29.
The aim of this review is to provide an overview of the history in support of the role of dietary saturated fatty acids (SFA) in the development of cardiovascular disease (CVD), and the controversy and consensus for the evidence in support of guidelines to remove and replace SFA with unsaturated fatty acids. The review will also examine the existence, origins, and implications for CVD risk of variability in serum LDL-cholesterol in response to these guidelines. While the quality of supporting evidence for the efficacy of restricting SFA on CVD risk has attracted controversy, this has helped to increase understanding of the inter-relationships between SFA, LDL-cholesterol and CVD, and reinforce confidence in this dietary recommendation. Nevertheless, there is significant inter-individual variation in serum LDL-C in response to this dietary change. The origins of this variation are multi-factorial and involve both dietary and metabolic traits. If serum biomarkers of more complex metabolic traits underlying LDL-responsiveness can be identified, this would have major implications for the targeting of these dietary guidelines to LDL-responders, to maximise the benefit to their cardiovascular health.
本综述的目的是概述支持膳食饱和脂肪酸(SFA)在心血管疾病(CVD)发展中作用的历史,以及支持用不饱和脂肪酸去除和替代SFA的指南证据的争议与共识。该综述还将探讨响应这些指南时血清低密度脂蛋白胆固醇变异性对CVD风险的存在、来源及影响。虽然限制SFA对CVD风险疗效的支持证据质量引发了争议,但这有助于增进对SFA、低密度脂蛋白胆固醇和CVD之间相互关系的理解,并增强对这一饮食建议的信心。然而,响应这种饮食变化时,血清低密度脂蛋白胆固醇存在显著的个体间差异。这种差异的来源是多因素的,涉及饮食和代谢特征。如果能够识别出低密度脂蛋白反应性背后更复杂代谢特征的血清生物标志物,这将对将这些饮食指南针对低密度脂蛋白反应者以最大程度地有益于其心血管健康产生重大影响。